We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Antisense therapy with zilganersen shows first success in Alexander disease. Learn about phase 1-3 studies where the drug improved walking speed and stabilized patient condition.
